Enterprise Financial Services Corp Arrowhead Pharmaceuticals, Inc. Transaction History

Enterprise Financial Services Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $1,984 - $2,888	-34 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $62 - $90	-1 Reduced 2.86%	34 $3,000
Q1 2021 May 13, 2021	BUY	$61.35 - $90.47 $61 - $90	1 Added 2.94%	35 $2,000
Q2 2020 Aug 04, 2020	BUY	$26.12 - $43.27 $888 - $1,471	34 New	34 $1,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.06B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.